Top Premarket Decliners

MT Newswires Live08-13

Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.

Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior session. The company said Wednesday that the Armed Forces Radiobiology Research Institute initiated a US government-funded study evaluating its drug, Entolimod, for radiation-induced gastrointestinal injury.

Founder Group (FGL) shares were down 26% following a 3.2% gain in the previous session.

The company's subsidiary announced a new contract to build a 1.78 MW-peak rooftop solar system for an aquaculture shrimp farm in Kedah, Malaysia.

Netcapital (NCPL) stock was 25% lower after the company released an official CEO statement addressing the civil fraud complaint filed by the US Securities and Exchange Commission against the company and certain directors.

Outlook Therapeutics (OTLK) shares were down 24% pre-bell after it priced a public offering late Wednesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2659159403?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-13 19:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2659159403","market":"sg","top_or_hot":-1,"title":"Top Premarket Decliners","media":"MT Newswires Live","content":"<html><body><p> Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.</p><p>Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior session. The company said Wednesday that the Armed Forces Radiobiology Research Institute initiated a US government-funded study evaluating its drug, Entolimod, for radiation-induced gastrointestinal injury.</p><p>Founder Group (FGL) shares were down 26% following a 3.2% gain in the previous session.</p><p>The company's subsidiary announced a new contract to build a 1.78 MW-peak rooftop solar system for an aquaculture shrimp farm in Kedah, Malaysia.</p><p>Netcapital (NCPL) stock was 25% lower after the company released an official CEO statement addressing the civil fraud complaint filed by the US Securities and Exchange Commission against the company and certain directors.</p><p>Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares were down 24% pre-bell after it priced a public offering late Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Premarket Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Premarket Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-13 19:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.</p><p>Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior session. The company said Wednesday that the Armed Forces Radiobiology Research Institute initiated a US government-funded study evaluating its drug, Entolimod, for radiation-induced gastrointestinal injury.</p><p>Founder Group (FGL) shares were down 26% following a 3.2% gain in the previous session.</p><p>The company's subsidiary announced a new contract to build a 1.78 MW-peak rooftop solar system for an aquaculture shrimp farm in Kedah, Malaysia.</p><p>Netcapital (NCPL) stock was 25% lower after the company released an official CEO statement addressing the civil fraud complaint filed by the US Securities and Exchange Commission against the company and certain directors.</p><p>Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares were down 24% pre-bell after it priced a public offering late Wednesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FGL","symbol_name":"Founder Group Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2659159403","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2659159403","pubTimestamp":1786620654,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior ses","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FGL":"Founder Group Ltd","OTLK":"Outlook Therapeutics, Inc.","BK4082":"医疗保健设备","BK4139":"生物科技","NCPL":"Netcapital Inc.","BK4129":"建筑与工程","VBIO":"Valion Bio Inc","BK4135":"资产管理与托管银行","BK4200":"专卖店","LESL":"Leslie's, Inc."},"translate_title":"盘前跌幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OTLK":1,"LESL":1,"FGL":1,"NCPL":1,"VBIO":1},"content_text":"Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior session. The company said Wednesday that the Armed Forces Radiobiology Research Institute initiated a US government-funded study evaluating its drug, Entolimod, for radiation-induced gastrointestinal injury.Founder Group (FGL) shares were down 26% following a 3.2% gain in the previous session.The company's subsidiary announced a new contract to build a 1.78 MW-peak rooftop solar system for an aquaculture shrimp farm in Kedah, Malaysia.Netcapital (NCPL) stock was 25% lower after the company released an official CEO statement addressing the civil fraud complaint filed by the US Securities and Exchange Commission against the company and certain directors.Outlook Therapeutics (OTLK) shares were down 24% pre-bell after it priced a public offering late Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2659159403","isCrawlerRequest":true}